PROAACT- Admin Supplement

项目总结/摘要 这是对Michelle Lin，MD，MPH，MS和Will的K23奖的行政补充 支持她过渡到一个独立的医生科学家，专注于改善病人- 哮喘和其他急性呼吸道疾病的急诊科（艾德）护理的报告结局 心肺状况在美国，每12个人中就有1人患有哮喘，结果为1.9 每年有100万艾德就诊;然而，艾德护理对患者报告的结果的影响， 急性加重是未知的，这一差距限制了对干预措施的评价， 艾德哮喘护理。林博士开发了新的急性哮喘患者报告结果 护理和治疗（PROAACT）工具。在K23期间，林博士将1）评估有效性 PROAACT仪器的可靠性; 2）测试是否接收到更多的指南一致性 艾德护理与改善PROAACT反应相关;和3）评估相关性 PROAACT评分与随后的艾德复查和住院之间的关系，这将告知 在未来的风险调整模型中纳入PROAACT和其他候选预测因子。到 为了实现这些目标，林博士将承担一个综合课程，包括密集的 在以患者为中心的研究，仪器开发和 包括心理测量方法，临床数据管理和新方法， 应用地理空间技术纳入社会和环境因素的成果计量 已知对哮喘和健康结果有不同影响的数据。林博士的职业发展 培训活动还包括建立同行和合作者的研究网络， 与当地社区的哮喘患者接触，并参与国家科学研究， 会议.林博士的导师团队由具有患者专业知识的国家领导人组成- 面向哮喘和急诊医学研究，以患者为中心的结果研究， 工具开发、卫生保健质量测量和结果评估。的 该奖项将使林博士在患者报告结果性能指标方面发展专业知识 发展，成为以患者为中心的哮喘和急救护理研究的领导者， 使她能够过渡到一个独立的临床研究者，专注于开发，测量 并改善哮喘和其他心肺疾病的患者报告结果。 这一补充将提供额外的资源，以确保林博士的持续生产力 母体K23将导致成人艾德哮喘患者的新型PROM， 了解艾德护理如何影响患者报告的结果，并使干预措施能够 改善对患有哮喘的艾德患者重要的结果。

PROJECT SUMMARY/ ABSTRACT This is an administrative supplement to the K23 award of Michelle Lin, MD, MPH, MS, and will support her transition to an independent physician scientist focused on improving patient- reported outcomes for emergency department (ED) care of asthma and other acute cardiopulmonary conditions. Asthma affects 1 in every 12 persons in the U.S., resulting in 1.9 million ED visits annually; however, the impact of ED care on patient-reported outcomes after acute exacerbations is unknown—a gap which limits the evaluation of interventions to improve ED asthma care. Dr. Lin has developed the novel Patient-Reported Outcomes for Acute Asthma Care and Treatment (PROAACT) instrument. During this K23, Dr. Lin will 1) evaluate the validity and reliability of the PROAACT instrument; 2) test whether receiving more guideline-concordant ED care is associated with improved PROAACT responses; and 3) evaluate the association between PROAACT scores and subsequent ED revisits and hospitalizations, which will inform the inclusion of PROAACT and other candidate predictors in future risk adjustment models. To achieve these aims, Dr. Lin will undertake an integrated curriculum consisting of intensive mentorship and didactic coursework in patient-centered research, instrument development and validation including psychometric methods, clinical data management, and novel approaches to outcome measurement applying geospatial techniques to incorporate social and environmental data known to differentially affect asthma and health outcomes. Dr. Lin’s career development and training activities also include building a research network of peers and collaborators, engaging with asthma patients in local communities, and participating in national scientific meetings. Dr. Lin’s mentorship team consists of national leaders with expertise in patient- oriented asthma and emergency medicine research, patient-centered outcomes research, instrument development, health care quality measurement, and outcome assessment. The award will allow Dr. Lin to develop expertise in patient-reported outcome performance measure development, become a leader in patient-centered asthma and emergency care research, and enable her transition to an independent clinical investigator focused on developing, measuring and improving patient-reported outcomes for asthma and other cardiopulmonary conditions. This supplement will provide additional resources to ensure Dr. Lin’s continued productivity on the parent K23, which will result in a novel PROM for adult ED asthma patients, advance the understanding of how ED care impacts patient-reported outcomes, and enable interventions to improve outcomes that matter to ED patients with asthma.